Primary aldosteronism

Evidence against a second epidemic

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Primary aldosteronism is widely held to be the most common cause of identifiable (secondary) hypertension, reported to be present in 6-10% of all hypertensive patients. This belief reflects the widespread use of the aldosterone-to-renin ratio (ARR) as a screening test. Unfortunately, the ARR is often wrong, leading to even more expensive testing that is also often misleading but that may then lead to potentially harmful additional measures. This review provides evidence that referral bias has markedly inflated the estimates of this condition and recommends a much less aggressive approach to the diagnosis of this condition based on more limited testing and the use of mineralocorticoid receptor antagonists in the treatment of most hypertensive patients.

Original languageEnglish (US)
Pages (from-to)1899-1902
Number of pages4
JournalJournal of Hypertension
Volume30
Issue number10
DOIs
StatePublished - Oct 2012

Fingerprint

Hyperaldosteronism
Aldosterone
Renin
Mineralocorticoid Receptor Antagonists
Referral and Consultation
Hypertension
Therapeutics

Keywords

  • adrenalectomy
  • aldosterone-to-renin ratio
  • mineralocorticoid receptor antagonists
  • primary aldosteronism

ASJC Scopus subject areas

  • Internal Medicine
  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Primary aldosteronism : Evidence against a second epidemic. / Kaplan, Norman M.

In: Journal of Hypertension, Vol. 30, No. 10, 10.2012, p. 1899-1902.

Research output: Contribution to journalArticle

@article{b56130ca0a474dc28866c9addc255019,
title = "Primary aldosteronism: Evidence against a second epidemic",
abstract = "Primary aldosteronism is widely held to be the most common cause of identifiable (secondary) hypertension, reported to be present in 6-10{\%} of all hypertensive patients. This belief reflects the widespread use of the aldosterone-to-renin ratio (ARR) as a screening test. Unfortunately, the ARR is often wrong, leading to even more expensive testing that is also often misleading but that may then lead to potentially harmful additional measures. This review provides evidence that referral bias has markedly inflated the estimates of this condition and recommends a much less aggressive approach to the diagnosis of this condition based on more limited testing and the use of mineralocorticoid receptor antagonists in the treatment of most hypertensive patients.",
keywords = "adrenalectomy, aldosterone-to-renin ratio, mineralocorticoid receptor antagonists, primary aldosteronism",
author = "Kaplan, {Norman M}",
year = "2012",
month = "10",
doi = "10.1097/HJH.0b013e3283559a03",
language = "English (US)",
volume = "30",
pages = "1899--1902",
journal = "Journal of Hypertension",
issn = "0263-6352",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - Primary aldosteronism

T2 - Evidence against a second epidemic

AU - Kaplan, Norman M

PY - 2012/10

Y1 - 2012/10

N2 - Primary aldosteronism is widely held to be the most common cause of identifiable (secondary) hypertension, reported to be present in 6-10% of all hypertensive patients. This belief reflects the widespread use of the aldosterone-to-renin ratio (ARR) as a screening test. Unfortunately, the ARR is often wrong, leading to even more expensive testing that is also often misleading but that may then lead to potentially harmful additional measures. This review provides evidence that referral bias has markedly inflated the estimates of this condition and recommends a much less aggressive approach to the diagnosis of this condition based on more limited testing and the use of mineralocorticoid receptor antagonists in the treatment of most hypertensive patients.

AB - Primary aldosteronism is widely held to be the most common cause of identifiable (secondary) hypertension, reported to be present in 6-10% of all hypertensive patients. This belief reflects the widespread use of the aldosterone-to-renin ratio (ARR) as a screening test. Unfortunately, the ARR is often wrong, leading to even more expensive testing that is also often misleading but that may then lead to potentially harmful additional measures. This review provides evidence that referral bias has markedly inflated the estimates of this condition and recommends a much less aggressive approach to the diagnosis of this condition based on more limited testing and the use of mineralocorticoid receptor antagonists in the treatment of most hypertensive patients.

KW - adrenalectomy

KW - aldosterone-to-renin ratio

KW - mineralocorticoid receptor antagonists

KW - primary aldosteronism

UR - http://www.scopus.com/inward/record.url?scp=84866545065&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866545065&partnerID=8YFLogxK

U2 - 10.1097/HJH.0b013e3283559a03

DO - 10.1097/HJH.0b013e3283559a03

M3 - Article

VL - 30

SP - 1899

EP - 1902

JO - Journal of Hypertension

JF - Journal of Hypertension

SN - 0263-6352

IS - 10

ER -